相关实验视频

Updated: Jul 18, 2025

A Simple Approach to Induce Experimental Autoimmune Neuritis in C57BL/6 Mice for Functional and Neuropathological Assessments

A Simple Approach to Induce Experimental Autoimmune Neuritis in C57BL/6 Mice for Functional and Neuropathological Assessments

Published on: November 9, 2017

抗髓相关的葡萄糖蛋白神经病变:我们在哪里?

Amro Maher Stino¹, Bakri Elsheikh², Jeffrey A Allen³

¹Department of Neurology, Division of Neuromuscular Medicine, University of Michigan, Ann Arbor, Michigan, USA.

|August 21, 2023

概括

抗髓相关葡萄糖蛋白 (MAG) 神经病变是一种渐进的自身免疫性疾病,缺乏有效的治疗方法. 本综述更新了抗MAG神经病的结果测量和生物标志物,强调了挑战和新的治疗药物.

科学领域:

神经免疫学神经免疫学
周围神经系统疾病周围神经系统疾病
自免疫性疾病自免疫性疾病

背景情况:

骨髓相关葡萄糖蛋白 (MAG) 是渐进性自身免疫外围神经病变中的关键抗原.
患者患上动力衰竭,感官丧失和步行不稳定,残疾缓慢累积.
目前的治疗方法往往不符合标签,缺乏已证明的疾病修饰功效.

研究的目的:

提供关于抗MAG神经病变的临床计量结果测量和疾病活性生物标志物的最新信息.
为了突出开发有效的治疗方法的挑战,这种缓慢渐进的条件.
讨论新兴的治疗药物和管理策略.

主要方法:

对抗MAG神经病变的结果测量和生物标志物的现有文献的审查.
分析当前临床测量工具的局限性,例如INCAT残疾分数.
讨论新型治疗候选药物及其潜在影响.

主要成果:

现有的结果指标,如INCAT得分,对于检测抗MAG神经病变的变化是不敏感的.
之前的临床试验中,Rituximab没有显著的益处.
新兴疗法包括铁氨酸激酶抑制剂和先进的B细胞消耗剂.

结论:

在抗MAG神经病症中,需要验证的结果测量和生物标志物至关重要.
正在研究新的治疗策略,以应对治疗挑战.
对于患者的评估和管理,实践的方法是必不可少的.

关键词:

抗MAG神经病变是一种神经病变.生物标志物生物标志物免疫疗法免疫疗法结果衡量结果的措施.这就是Rituximab.

更多相关视频

High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum

High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum

Published on: November 23, 2013

Nerve Ultrasound Protocol to Detect Dysimmune Neuropathies

Nerve Ultrasound Protocol to Detect Dysimmune Neuropathies

Published on: October 7, 2021

相关概念视频

Myasthenia Gravis: Overview and Treatment

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...

Myasthenia Gravis: Diagnostic Tests

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...